Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Synergy Rx

Two GLP-1 desks, one scoreboard. We put CoreAge Rx and Synergy Rx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 145 · Grade C

Synergy Rx

Visit Synergy Rx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 67 on our six-factor Brief Score — The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

That doesn't make Synergy Rx a bad call — it's best for readers who want to verify who is actually prescribing and compounding their medication, and who will read past the first-month rate to the $249 or $399 they will pay from month two. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
54
Supply Reliability
95
82
Transparency
90
60
Access Breadth
93
62
Clinical Oversight
92
84
Track Record
88
66
CoreAge RxBrief Score 94 · 67Synergy Rx

Price, coverage & the tracker

CoreAge RxSynergy Rx
Brief Score94/100 (A)67/100 (C)
Semaglutide$99/mo$249/mo ongoing, compounded ($199 first month only) + an $80 visit fee charged whether or not you get medication
Tirzepatide$149/mo$399/mo ongoing, compounded ($349 first month only); the ODT bundles price HIGHER, at $399.67–$399.92/mo
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: Flat rate held for a third straight cycle — no first-month teaser to reset.

Synergy Rx: First reading, 7 August 2026. Ongoing month-to-month is $249 semaglutide and $399 tirzepatide; the $199 and $349 figures carried in older datasets are first-month-only rates. An $80 telehealth visit fee sits outside every headline and is charged whether or not medication is dispensed.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.